- Home
- MGEE vs OPCH Comparison
MGEE vs OPCH Comparison
Compare MGEE & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGEE | OPCH |
|---|---|---|
| Founded | 1855 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Nursing Services |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2001 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MGEE | OPCH |
|---|---|---|
| Price | $81.00 | $21.61 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $80.50 | $36.57 |
| AVG Volume (30 Days) | 282.0K | ★ 2.3M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.41% | N/A |
| EPS Growth | ★ 11.71 | 3.25 |
| EPS | ★ 1.32 | 0.29 |
| Revenue | N/A | ★ $4,998,202,000.00 |
| Revenue This Year | $4.02 | $7.21 |
| Revenue Next Year | $2.77 | $8.55 |
| P/E Ratio | ★ $62.15 | $76.66 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $72.16 | $18.01 |
| 52 Week High | $89.50 | $36.80 |
Technical Indicators
Market Signals| Indicator | MGEE | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 54.14 | 49.95 |
| Support Level | $80.90 | $20.82 |
| Resistance Level | $82.48 | $22.42 |
| Average True Range (ATR) | 1.93 | 0.65 |
| MACD | -0.17 | 0.06 |
| Stochastic Oscillator | 37.98 | 47.72 |
Price Performance
Historical ComparisonAbout MGEE MGE Energy Inc
MGE Energy provides electric service to 170,000 customers and natural gas service to 180,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.